Hanaro Medical Foundation Achieves Grade 1 in Drug Benefit Adequacy Evaluation - A Local Hospital Minimizing Antibiotic Use for Colds

Hanaro Medical Foundation Achieves Grade 1 in Drug Benefit Adequacy Evaluation - A Local Hospital Minimizing Antibiotic Use for Colds

Hanaro Medical Foundation Outpatient Clinic Achieves Grade 1 in Drug Benefit Adequacy Evaluation!

The Hanaro Medical Foundation Outpatient Clinic has been awarded Grade 1 in the Drug Benefit Adequacy Evaluation.

In this evaluation conducted by the Health Insurance Review and Assessment Service (HIRA), the antibiotic prescription rate for acute upper respiratory infections (such as colds) was 8.46% (compared to the national average of 45.20%), and the rate for acute lower respiratory infections (such as acute bronchitis) was 4.80% (compared to the national average of 61.86%). These figures are significantly lower than the overall hospital average, earning the clinic the highest rating of Grade 1 and the designation as a ‘Local Hospital Minimizing Antibiotic Use for Colds’.

※ A lower prescription rate indicates excellence, meaning the medical institution has minimized antibiotic use through voluntary management and improvement of medication practices, using antibiotics only when appropriate.

What is the Drug Benefit Adequacy Evaluation?

The Health Insurance Review and Assessment Service conducts the Drug Benefit Adequacy Evaluation to analyze prescriptions of major drugs that have a significant impact on public health. The goal is to reduce drug misuse and abuse, promote appropriate use, and improve overall national health.

Hanaro Medical Foundation Outpatient Clinic will continue to avoid unnecessary medication use in the future.

We will do our best to prioritize patient safety and satisfaction above all else.

Thank you.

#HanaroMedicalFoundation #HanaroMedicalFoundationJongnoCenter #HanaroMedicalFoundationOutpatientClinic #LocalHospitalMinimizingAntibioticUseForColds #DrugBenefitAdequacyEvaluationGrade1